A colleague asked me today when I would know it is time to sell CTIX. I told him with a pipeline of 18 products and the minds that seem to be at our disposal in the way of Dr M/Kard/PolyM personnel that CTIX has about a fine a research team for small molecule drugs as one could find anywhere and thus the revenue potential is always expanding. Why would you sell a company that should become a cash cow?
I then went into the listing of opportunities and explained how we didn't have just 18 products as the first 3 products (K,P, and B) each cover an entire spectrum of medicine in the way of cancer, autoimmune, and biotic/gastrointestinal etc. so that they alone could atone for tens upon tens of trials each, possibly even far greater. I then said if you had started with Pfizer, would you now sell all your holdings since the stock price is so high? Obviously not, and with CTIX having multiple high grossing revenue streams continuously coming on line, the future should only get better and better. I have other investments to sell off, CTIX is a holder for as long as I can envision.
That is why the day to day gyrations of the stock price mean little to me. This is a long term play and, if not sold, I see CTIX becoming a powerful pharmaceutical company with a pipeline of products far surpassing many of the current mid size pharmas. I see CTIX becoming known for spectrum wide solutions and a powerhouse in the design and development of small molecule drugs.
Market Data 
Markets 
AI
